» Articles » PMID: 12692045

Plasma Ghrelin Following Cure of Helicobacter Pylori

Overview
Journal Gut
Specialty Gastroenterology
Date 2003 Apr 15
PMID 12692045
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In the Western world, the incidence of oesophageal adenocarcinoma has increased over the last 30 years coinciding with a decrease in the prevalence of Helicobacter pylori. Trends of increasing oesophageal adenocarcinoma can be linked causally to increasing gastro-oesophageal reflux disease (GORD) which can be linked to an increasingly obese population. However, there is no plausible biological mechanism of association between H. pylori, obesity, and GORD. Ghrelin, a peptide produced in the stomach, which regulates appetite, food intake, and body composition, was studied in H. pylori positive asymptomatic subjects.

Methods: Plasma ghrelin, leptin, and gastrin were measured for six hours after an overnight fast, before and after cure of H. pylori in 10 subjects. Twenty four hour intragastric acidity was also assessed.

Results: After cure, median (95% confidence intervals) integrated plasma ghrelin increased from 1160.5 (765.5-1451) pg/ml x h to 1910.4 (1675.6-2395.6) pg/ml x h (p=0.002, Wilcoxon's rank sum test), a 75% increase. This was associated with a 14% increase in 24 hour intragastric acidity (p=0.006) and non-significant changes in leptin and gastrin. There was a significant positive correlation between plasma ghrelin and intragastric acidity (r(s) 0.44, p=0.05, Spearman's rank correlation).

Conclusions: After H. pylori cure, plasma ghrelin increased profoundly in asymptomatic subjects. This could lead to increased appetite and weight gain, and contribute to the increasing obesity seen in Western populations where H. pylori prevalence is low. This plausible biological mechanism links H pylori, through increasing obesity and GORD, to the increase in oesophageal adenocarcinoma observed in the West.

Citing Articles

Comparison of weight loss after Roux-en-Y gastric bypass in Helicobacter pylori-negative and Helicobacter pylori eradicated patients during five years follow-ups.

Farazmand B, Shahsavan M, Eghbali F, Pazouki A, Kermansaravi M Surg Endosc. 2023; 38(2):888-893.

PMID: 38082012 DOI: 10.1007/s00464-023-10578-w.


GHRL as a prognostic biomarker correlated with immune infiltrates and progression of precancerous lesions in gastric cancer.

Wang J, Liu D, Xie Y Front Oncol. 2023; 13:1142017.

PMID: 37469414 PMC: 10353738. DOI: 10.3389/fonc.2023.1142017.


Effect of Eradication on Body Weight: A Multicenter Propensity Score-matched Analysis in Korea.

Kim J, Baeg M, Bang C, Park J, Oh J J Neurogastroenterol Motil. 2023; 29(3):352-359.

PMID: 37417262 PMC: 10334196. DOI: 10.5056/jnm22179.


Nigella sativa powder for helicobacter pylori infected patients: a randomized, double-blinded, placebo-controlled clinical trial.

Yousefnejad H, Mohammadi F, Alizadeh-Naini M, Hejazi N BMC Complement Med Ther. 2023; 23(1):123.

PMID: 37069587 PMC: 10108520. DOI: 10.1186/s12906-023-03955-4.


: Have potential benefits been overlooked?.

Schubert J, Rayner C, Costello S, Roberts-Thomson I, Forster S, Bryant R JGH Open. 2022; 6(11):735-737.

PMID: 36406651 PMC: 9667403. DOI: 10.1002/jgh3.12842.


References
1.
Bado A, Levasseur S, Attoub S, Kermorgant S, Laigneau J, Bortoluzzi M . The stomach is a source of leptin. Nature. 1998; 394(6695):790-3. DOI: 10.1038/29547. View

2.
Furuta T, Shirai N, Xiao F, Takashima M, Hanai H . Effect of Helicobacter pylori infection and its eradication on nutrition. Aliment Pharmacol Ther. 2002; 16(4):799-806. DOI: 10.1046/j.1365-2036.2002.01222.x. View

3.
Richter T, List S, Muller D, Deutscher J, Uhlig H, Krumbiegel P . Five- to 7-year-old children with Helicobacter pylori infection are smaller than Helicobacter-negative children: a cross-sectional population-based study of 3,315 children. J Pediatr Gastroenterol Nutr. 2001; 33(4):472-5. DOI: 10.1097/00005176-200110000-00010. View

4.
Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M . Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab. 2001; 85(12):4908-11. DOI: 10.1210/jcem.85.12.7167. View

5.
Kojima M, Hosoda H, Matsuo H, Kangawa K . Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab. 2001; 12(3):118-22. DOI: 10.1016/s1043-2760(00)00362-3. View